Answers are grounded in this paper and cite their sources.
Technological advancements in ventricular assist device (VAD) support have resulted in progressive decreases in device size. This has allowed centers to push the lower limits of size for use in pediatric patients.1,2 These limits remain uncertain, however. Although the use of virtual implantation has been described with a total artificial heart in smaller adult patients,3 the application to pediatric patients undergoing systemic VAD implantation is less clear.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: